Original Research
Published on 21 Aug 2020
Bimekizumab, a Novel Humanized IgG1 Antibody That Neutralizes Both IL-17A and IL-17F
in Cytokines and Soluble Mediators in Immunity

- 22,831 views
- 75 citations
Original Research
Published on 21 Aug 2020
in Cytokines and Soluble Mediators in Immunity

Original Research
Published on 19 Aug 2020
in Cytokines and Soluble Mediators in Immunity

Correction
Published on 19 Aug 2020
in Cytokines and Soluble Mediators in Immunity
Review
Published on 18 Aug 2020
in Cytokines and Soluble Mediators in Immunity

Original Research
Published on 14 Aug 2020
in Cytokines and Soluble Mediators in Immunity

Mini Review
Published on 13 Aug 2020
in Cytokines and Soluble Mediators in Immunity

Original Research
Published on 11 Aug 2020
in Cytokines and Soluble Mediators in Immunity

Review
Published on 07 Aug 2020
in Cytokines and Soluble Mediators in Immunity

Review
Published on 07 Aug 2020
in Cytokines and Soluble Mediators in Immunity

Original Research
Published on 04 Aug 2020
in Cytokines and Soluble Mediators in Immunity

Original Research
Published on 04 Aug 2020
in Cytokines and Soluble Mediators in Immunity

Original Research
Published on 31 Jul 2020
in Cytokines and Soluble Mediators in Immunity

Mini Review
Published on 29 Jul 2020
in Cytokines and Soluble Mediators in Immunity

Opinion
Published on 29 Jul 2020
in Cytokines and Soluble Mediators in Immunity
Original Research
Published on 28 Jul 2020
in Cytokines and Soluble Mediators in Immunity

Original Research
Published on 28 Jul 2020
in Cytokines and Soluble Mediators in Immunity
